Eric Sussman

Represented a drug compounding company in an FCA matter in the District of Massachusetts involving allegations of fraud and kickbacks. Represented an international medical device manufacturer in FCA investigations and litigation in the District of Minnesota. Represented the CFO of publicly traded company in a DOJ/SEC securities fraud prosecution and related civil litigation matters in the Northern District of Illinois. Represented an electronic payment and electronic wage advancement company in a multi-state attorneys general investigation involving predatory lending practices. Represented a pharmaceutical CEO in an international insider trading prosecution brought by the U.S. Attorney's Office for the Southern District of Illinois. Represented a corporate employee in a DOJ investigation of suspected theft of sensitive government information. Represented a senior foreign executive charged by the DOJ with illegal arms trafficking in violation of the Arms Export Control Act. Represented hedge fund owners and managers on issues relating to disclosure obligations and potential liabilities. Represented a New York-based construction firm in connection with a DOJ investigation of alleged minority business fraud. Represented a wholesale food-distribution company in a USDA and DOJ criminal investigation. Represented the Bank of America in complex civil litigation involving allegations of financial fraud by senior executives at debtor companies. Represented a multinational company in a DOJ government contracting investigation. Represented a corporation and its senior executives in a criminal investigation involving export control violations for sales of products to Iran. Represented several Chicago-based financial services firms in connection with multiple SEC investigations of potential fraud and abuse. Represented court-appointed liquidators of hedge funds in the British Virgin Islands in ongoing federal litigation against the SEC and CFTC. Represented a high-frequency trading firm in multiple SEC investigations. Represented a senior AIG executive in regulatory investigations arising out of AIG's subprime-related losses. After investigations by the DOJ, the SEC, the U.K. Serious Fraud Office, and the U.K. Financial Services Authority, no charges were brought against AIG or any of its current or former employees. Represented an international hedge fund in connection with SEC and DOJ securities fraud proceedings against New York attorney Marc Dreier and related bankruptcy litigation. Represented Bodybuilding.com, the largest internet retailer of dietary supplements in the world, in a DOJ and FDA criminal investigation into the sale of misbranded drugs in violation of the Food, Drug, and Cosmetic Act. Represented a former contracting engineer for BP in a DOJ criminal prosecution alleging obstruction of justice. Represented international pharmaceutical companies and private equity funds in FCPA internal investigations and counselling. Represented a former executive at General Motors in the ongoing DOJ and SEC investigation involving ignition switches. Represented a Japanese manufacturing company and senior Japanese executives in multiple DOJ antitrust investigations involving the auto parts industry. Represented numerous international medical device companies in FCPA investigations before the DOJ FCPA Unit involving Brazil, China, India, Russia, Ukraine, Pakistan and various European countries. Represented respondents in an ICC arbitration in Singapore concerning a DOJ FCA investigation and allegations of fraud arising from the multi-billion dollar acquisition of an international pharmaceutical company. Represented an international drug maker in DOJ investigations involving allegations of fraud, cGMP violations, and obstruction of justice. Represented a drug compounding company in DEA investigations involving allegations of distribution of controlled substances. Represented an international medical device company in a DOJ investigation involving allegations of fraud, misbranding and violations of the Computer Fraud and Abuse Act by a reseller of ultrasound devices. Represented multiple surgical groups in an FCA matter involving allegations of fraud and kickbacks from a medical device manufacturer, in the SDNY. Represented an international business process outsourcing company in an Illinois Attorney General investigation into potential data security violations.

Several employees of digital asset platforms unexpectedly found themselves the focus of insider trading actions brought by the Department of Justice (DOJ) and the Securities and Exchange Commission (SEC) earlier this summer. While some would say digital assets fall outside the government’s jurisdiction, the government actions highlight the pressing need for digital asset businesses to create robust policies and procedures to prevent prohibited trading activity on their platforms, systems, and interfaces.

This year’s complimentary in-person briefing offers a complete update on recent developments featuring the views of government speakers, legal professionals from top law firms, corporate counsel and advisers. The agenda reflects the latest topics of interest and how they will affect your strategy.